Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18951618 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Childhood Asthma Research and Education (CARE) Network Trial - Montelukast or Azithromycin for Reduction of Inhaled Corticosteroids in Childhood Asthma (MARS)
Condition: Asthma
Interventions: Drug: Budesonide + Salmeterol  + Azithromycin;   Drug: Budesonide + Salmeterol + Montelukast;   Drug: Budesonide + Salmeterol + Placebo

Indicates status has not been verified in more than two years